Khalid Mumtaz is a Gastroenterology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 279 publications with 3,642 citations (h-index 29).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-6255Provider last certified this registry record 20 Apr 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Madrigal PharmaceuticalsProgram year20241 payment
- INTERCEPT PHARMACEUTICALS, INC.Program year20231 payment
- Mallinckrodt Hospital Products Inc.Program year20227 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.6%Corticosteroid11.4%Prednisone100%Part D≥39 patientsProton pump inhibitor7.8%Pantoprazole Sodium69%Omeprazole31%Part D≥30 patients+ 5 more classes in this area
Cardiovascular
31.9%Aldosterone antagonist (MRA)10%Spironolactone100%Part D≥60 patientsStatin7.4%Pravastatin Sodium38%Atorvastatin Calcium27%Rosuvastatin Calcium17%Simvastatin17%Part D<11 patients+ 4 more classes in this area
Cancer & immunology
21.6%Calcineurin inhibitor17.6%Tacrolimus87%Cyclosporine Modified9%Envarsus Xr4%Part D<11 patientsKinase inhibitor2.7%Everolimus100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Preoperative Glucagon‐Like Peptide‐1 Receptor Agonist on Outcomes Following Major Surgery
World Journal of Surgery
2025 - Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
World Journal of Gastroenterology
2022 - Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Journal of Cancer Research and Clinical Oncology
2022 - Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
World Journal of Hepatology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”